Depletion of nigrostriatal and forebrain tyrosine hydroxylase by S-adenosylmethionine: A model that may explain the occurrence of depression in Parkinson's disease

Life Sciences

Volumn 61, Issue 5, 1997, Pages 495-502

  Charlton, Clivel G ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Immunoractivity; S adenosyl methionine; Tyrosine hydroxylase

Indexed keywords

S ADENOSYLMETHIONINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; FOREBRAIN; HYPOKINESIA; IMMUNOREACTIVITY; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; RAT; TREMOR;

ANIMALS; CORPUS STRIATUM; DEPRESSION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALE; PARKINSON DISEASE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; S-ADENOSYLMETHIONINE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0030759217     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00409-8     Document Type: Article

References (30)

1. J.R. COOPER, F.E. BLOOM And R.H. ROTH, (1986). The Biochemical Basis of Neuropharmacology, Oxford University Press, New York. 5th Ed, Cpt. 10(1986).
2. M.A. LLOYD, L. DAVIDSSON and O. HORNYKIEWICZ, O, J. Pharmacol. Exp. Ther. 195 453-464 (1975).
3. T. NAGATSU, T. KATO, I. NAGATSU, Y. KONDO, S. INAGAKI, R. IIZUKA and H. NARABAYASHI, Adv. Neurol. 24 283-292(1979).
4. W.D. RAUSCH, Y. HIRATA, T. NAGATSU, P. RIEDERER and K. JELLINGER, J. Neurochem. 50 202-208(1988).
5. O. HONYKIEWICZ , Pharmacol. Rev. 18 925-964 (1966).
6. C. TRETIAKOFF, Thesis, Paris (1919). Cited in W. SHULTZ, Prog. Neurol. 18 121-166 (1982).
7. C. TRETIAKOFF, Thesis, Paris (1919). Cited in W. SHULTZ, Prog. Neurol. 18 121-166 (1982).
8. C. FOIX and J. NICOLESCO, Masson, Paris (1925). Cited in K. Jellinger, Adv. Neurol. 45 1-18 (1986).
9. C. FOIX and J. NICOLESCO, Masson, Paris (1925). Cited in K. Jellinger, Adv. Neurol. 45 1-18 (1986).
10. J.G. GREENFIELD and F.D BOSANQUEST, J. Neurol Neurosurg. Psychiat. 16 213-221(1953).
11. J.L CUMMINGS, Am. J. Psychiat. 149 443-454(1992).
12. H.A. RING, C.J. BENCH, M.R. TRIMBLE, D.J. BROOKS, S.J. FRACKOWIAK and R.J. DOLAN, Brit. J. Psychia. 165 333-339(1994).
13. H.S. MAYBERG, S.E. STARKSTEIN, B. SADZOT, T. PREZIOSI, P.L. ANDREZEJEWSKI, R.F. DANNALS, H.N. WAGNER and R.G. ROBINSON, Ann. Neurol. 28 57-64(1990).
14. C.G. CHARLTON and B. CROWELl, Jr., Pharm. Biochem. Behav. 43 423-431(1992).
15. C.G. CHARLTON and J. MACK, Mol. Neurobiol. 9 149-161(1994).
16. B.G. CROWELL, JR., R. BENSON, D. SHOCKLEY and C.G. CHARLTON, Behav. Neural. Biol. 59 186-193(1993).
17. C. G. CHARLTON and B. CROWELL, Jr., Mol. Chem. Neuropathol. 26(3), 269-281(1995).
18. M.A. COLLINS, E.J. NEAFSEY, K. MATSUBARA, R.J. COBUZZI and H. ROLLEMA, Brain Res. 570 154-160(1992).
19. J.J. VOLPE and L. LASTER, J. Neurochem.17 413-424(1970).
20. L.I. MAYS, E. BOREK and C.E. FINCH, Nature 243 411-413(1973).
21. G. STRAMENTINOLI, M. GUALANA, E. CATTO and S. ALGERI, J. Gerontol. 42, 392-394(1977).
22. L. TUOMISTO, (1977), J. Neurochem. 28 271-276 (1977).
23. O.Z. SELLINGER, C.M. KRAMER, A. CONGER and G.S. DUBOFF, Mech. Aging Dev. 43 161-173(1988).
24. A. GHARIB, N. SARDA, B. CHABANNES, L. CRONENBERGER and H. PACHECO, J. Neurochem. 38 810-815(1982).
25. C. PERRONE-CAPANO and U. DE PORZIO, Bio Assays 18(10) 817-824 (1996).
26. P. SEEMAN, H. C. GUAN and H. H. VAN TOL, Nature 365 441-445 (1993).
27. J. MALLET, R. MELONI and C. LAURET, Curr Opin Gen Dev 4 419-426 (1994).
28. H.U. WELTZEIN, Acta 559 259-273 (1979).
29. C.G. CHARLTON, Society for Neurosci. Abst. #486.16 pp250 (1995).
30. J.A MORTIMER, K.J. CHRIS TENSEN and D.D. WEBSTER, Parkinson Dementia. In, Handbook of Clinical Neurology, Neurobehavioral Disorders, ed, J. A.M. Fredericks, vol.12 371-384.Elsevier, Amsterdam (1985).